HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H R Lijnen Selected Research

N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamide

1/2012Effect of gelatinase inhibition on adipogenesis and adipose tissue development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H R Lijnen Research Topics

Disease

15Obesity
01/2018 - 04/2000
12Thrombosis (Thrombus)
12/2012 - 06/2000
6Body Weight (Weight, Body)
01/2009 - 03/2002
5Ischemic Stroke
01/2009 - 04/2004
5Vascular System Injuries
01/2004 - 06/2000
5Neointima
01/2004 - 06/2000
4Myocardial Infarction
08/2009 - 04/2000
3Hemorrhage
12/2012 - 02/2001
3Insulin Resistance
02/2011 - 01/2005
3Inflammation (Inflammations)
12/2007 - 02/2001
3Aneurysm (Aneurysms)
05/2002 - 07/2001
2Thrombotic Thrombocytopenic Purpura
01/2018 - 09/2010
2Thrombocytopenia (Thrombopenia)
01/2018 - 02/2001
2Sepsis (Septicemia)
12/2007 - 01/2005
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2007 - 07/2005
2Atherosclerotic Plaque (Atheroma)
03/2006 - 05/2002
2Infarction (Infarctions)
07/2005 - 02/2001
2Glomerulonephritis
01/2005 - 09/2003
2Neoplasms (Cancer)
01/2005 - 04/2001
2Atherosclerosis
01/2005 - 07/2001
2Electric Injuries
01/2004 - 01/2001
2Hypertrophy
03/2002 - 06/2001
2Weight Gain
02/2002 - 04/2000
1Thromboembolism
12/2012
1Glucose Intolerance
02/2011
1Thrombocytopenic Purpura (Thrombopenic Purpura)
09/2010
1Thrombotic Microangiopathies
09/2010
1Melanoma (Melanoma, Malignant)
08/2009
1Multiple Sclerosis
04/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2008
1Neuroinflammatory Diseases
04/2008
1Endotoxemia
12/2007
1Stroke (Strokes)
07/2005
1Brain Injuries (Brain Injury)
07/2005
1Wounds and Injuries (Trauma)
05/2005
1Edema (Dropsy)
05/2005
1Necrosis
05/2005
1Asthma (Bronchial Asthma)
01/2005
1Rheumatoid Arthritis
01/2005
1Fibrosis (Cirrhosis)
01/2005
1Pulmonary Embolism
04/2004
1Venous Thrombosis (Deep-Vein Thrombosis)
04/2004
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2004
1Cardiovascular Diseases (Cardiovascular Disease)
07/2001
1Heart Rupture
07/2001
1Heart Failure
07/2001
1Vascular Remodeling
07/2001
1Unstable Angina
06/2001

Drug/Important Bio-Agent (IBA)

12Plasminogen Activator Inhibitor 1IBA
12/2012 - 04/2000
11Matrix Metalloproteinases (MMPs)IBA
01/2012 - 01/2001
10FibrinIBA
12/2012 - 06/2000
10Plasminogen Activators (Plasminogen Activator)IBA
04/2008 - 04/2000
7FibrinolysinFDA Link
09/2010 - 01/2001
7PlasminogenIBA
08/2009 - 01/2001
5Tissue Plasminogen Activator (Alteplase)FDA Link
08/2009 - 02/2002
5Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2002 - 01/2001
3Matrix Metalloproteinase InhibitorsIBA
01/2012 - 01/2001
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2008 - 01/2001
3Tissue Inhibitor of Metalloproteinase-1IBA
05/2002 - 01/2001
2thiamine triphosphorate (TTP)IBA
01/2018 - 09/2010
2Fibrinogen (Factor I)FDA Link
04/2008 - 02/2001
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2007 - 06/2001
2Glucose (Dextrose)FDA LinkGeneric
06/2005 - 03/2004
2Insulin (Novolin)FDA Link
06/2005 - 03/2004
2CholesterolIBA
05/2002 - 09/2001
2ApolipoproteinsIBA
05/2002 - 09/2001
2Apolipoproteins E (ApoE)IBA
05/2002 - 09/2001
2Biological ProductsIBA
03/2002 - 01/2001
2Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2001 - 06/2000
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018
1von Willebrand FactorIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
12/2012
1N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamideIBA
01/2012
1Estrogens (Estrogen)FDA Link
02/2011
1fumagillinIBA
04/2010
1Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2009
1Clopidogrel (Plavix)FDA Link
03/2009
1Vascular Endothelial Growth Factor DIBA
01/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2009
13- methyl- 2- (4- (3- p- tolyl(1,2,4)oxadiazol- 5- yl)benzenesulfonylamino)butyric acidIBA
07/2008
1LipopolysaccharidesIBA
12/2007
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2007
1Phosphotransferases (Kinase)IBA
09/2007
1vatalanib (PTK787)IBA
09/2007
1Tyrosine (L-Tyrosine)FDA Link
09/2007
1InterleukinsIBA
05/2005
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004
1Actins (F Actin)IBA
01/2004
1AntigensIBA
03/2002
1Rubber (Elastica)IBA
09/2001
1GelatinasesIBA
06/2001
1Heparin (Liquaemin)FDA LinkGeneric
06/2001
1Pharmaceutical PreparationsIBA
06/2001
1efegatranIBA
06/2001
1Monoclonal AntibodiesIBA
04/2001
1AngiostatinsIBA
04/2001

Therapy/Procedure

3Ligation
07/2005 - 02/2001
1Therapeutics
02/2011
1Oral Administration
09/2007